HB 1169·SD·house
classify medetomidine as a Schedule III controlled substance and establish permissible uses.
Signed into LawFiled Jan 28, 2026
Sponsor: Garcia
Latest Action
Signed by the Governor
Mar 9, 2026
Track this bill
Get real-time alerts when HB 1169 changes status, plus AI-powered summaries and stage predictions.
Sign up free